Onyx Pharmaceuticals, Inc. Stock
Equities
US6833991093
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2013 | Gilead Sciences, Inc. : Bradway's patient dealmaking brings Onyx to Amgen | RE |
2013 | Onyx Pharmaceuticals, Inc. : Onyx deal expected to give Amgen a big boost | RE |
1st Jan change | Capi. | |
---|---|---|
-0.29% | 103B | |
+3.71% | 96.73B | |
+1.66% | 21.31B | |
-16.23% | 21.21B | |
-6.82% | 18.79B | |
-41.41% | 16.37B | |
-22.96% | 13.68B | |
+6.76% | 13.44B | |
+22.06% | 10.98B |
- Stock Market
- Equities
- Stock